Literature DB >> 16290992

The relationship between C-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS).

Donald W Bowden1, Leslie A Lange, Carl D Langefeld, K Bridget Brosnihan, Barry I Freedman, J Jeffrey Carr, Lynne E Wagenknecht, David M Herrington.   

Abstract

BACKGROUND: Epidemiological studies suggest that levels of C-reactive protein (CRP) predict cardiovascular disease (CVD). We have evaluated the relationship between CRP and subclinical CVD in a study cohort at high risk of CVD.
METHODS: The DHS is a single-center, family-based study of the genetic and environmental components of CVD in type 2 diabetes mellitus (T2DM). We evaluated 666 subjects (551 T2DM affected and 115 unaffected) with an average age of 61 years. Measures of coronary artery calcium (CAC), intimal-medial thickness (IMT) of the common carotid artery, and CRP were obtained on all subjects.
RESULTS: C-reactive protein is positively and significantly associated with female sex, body mass index, and smoking and is negatively and significantly associated with age and statin use. Generalized estimating equations were used to test whether CRP was associated with each subclinical CVD measure (presence/absence of CAC, quantity of CAC, and IMT) adjusting for covariates and correlation among siblings. Stratified analyses were conducted to examine whether these associations differed across sex and statin use. In the overall analysis, CRP was not significantly associated with IMT or presence of CAC but was negatively and significantly associated with quantity of CAC (P = .01). When covariates were added, the relationship was no longer significant. Similar patterns were observed in stratified analyses based on sex, statin use, and diabetes status: weak but negative association of CAC with CRP, which became nonsignificant with adjustment for covariates.
CONCLUSIONS: In a population at high risk for CVD, there was no evidence of incremental association of CRP levels with measures of subclinical CVD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16290992     DOI: 10.1016/j.ahj.2005.01.017

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes.

Authors:  Atif N Qasim; Venkata Budharaju; Nehal N Mehta; Caitlin St Clair; Samira Farouk; Seth Braunstein; Mark Schutta; Nayyar Iqbal; Daniel J Rader; Muredach P Reilly
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

2.  Genetic epidemiology of subclinical cardiovascular disease in the diabetes heart study.

Authors:  D W Bowden; A B Lehtinen; J T Ziegler; M E Rudock; J Xu; L E Wagenknecht; D M Herrington; S S Rich; B I Freedman; J J Carr; C D Langefeld
Journal:  Ann Hum Genet       Date:  2008-04-29       Impact factor: 1.670

3.  Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT).

Authors:  Aramesh Saremi; Robert J Anderson; Ping Luo; Thomas E Moritz; Dawn C Schwenke; Mathew Allison; Peter D Reaven
Journal:  Atherosclerosis       Date:  2008-08-05       Impact factor: 5.162

4.  Correlates of coronary artery calcified plaque in blacks and whites with type 2 diabetes.

Authors:  Lynne E Wagenknecht; Jasmin Divers; Alain G Bertoni; Carl D Langefeld; J Jeffrey Carr; Donald W Bowden; Steven C Elbein; Steven Shea; Cora E Lewis; Barry I Freedman
Journal:  Ann Epidemiol       Date:  2011-01       Impact factor: 3.797

Review 5.  Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications.

Authors:  Donald W Bowden; Amanda J Cox; Barry I Freedman; Christina E Hugenschimdt; Lynne E Wagenknecht; David Herrington; Subhashish Agarwal; Thomas C Register; Joseph A Maldjian; Maggie C-Y Ng; Fang-Chi Hsu; Carl D Langefeld; Jeff D Williamson; J Jeffrey Carr
Journal:  Rev Diabet Stud       Date:  2010-11-10

6.  Genetic mapping of vascular calcified plaque loci on chromosome 16p in European Americans from the diabetes heart study.

Authors:  Allison B Lehtinen; Amanda J Cox; Julie T Ziegler; V Saroja Voruganti; Jianzhao Xu; Barry I Freedman; J Jeffrey Carr; Anthony G Comuzzie; Carl D Langefeld; Donald W Bowden
Journal:  Ann Hum Genet       Date:  2011-03       Impact factor: 1.670

7.  Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.

Authors:  Allison C Ross; Nesrine Rizk; Mary Ann O'Riordan; Vikram Dogra; Dalia El-Bejjani; Norma Storer; Danielle Harrill; Marisa Tungsiripat; Jerome Adell; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2009-10-01       Impact factor: 9.079

8.  The association of pericardial fat with calcified coronary plaque.

Authors:  Jingzhong Ding; Stephen B Kritchevsky; Tamara B Harris; Gregory L Burke; Robert C Detrano; Moyses Szklo; J Jeffrey Carr
Journal:  Obesity (Silver Spring)       Date:  2008-05-29       Impact factor: 5.002

9.  Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.

Authors:  Amanda J Cox; Maggie C-Y Ng; Jianzhao Xu; Carl D Langefeld; Kenneth L Koch; Paul A Dawson; J Jeffrey Carr; Barry I Freedman; Fang-Chi Hsu; Donald W Bowden
Journal:  Atherosclerosis       Date:  2013-04-19       Impact factor: 5.162

10.  Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects.

Authors:  Aneta Mankowska; Joanna Pollak; Grazyna Sypniewska
Journal:  EJIFCC       Date:  2006-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.